DROIA VENTURES

droia-ventures-logo

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in newly founded or early-stage platform companies that apply novel science and innovative technologies to bring first-in-class drug candidates to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patient lives.

#People #Financial #More

DROIA VENTURES

Social Links:

Industry:
Finance

Founded:
2011-01-01

Status:
Active

Contact:
+35220301236

Email Addresses:
contact@droiagroup.com

Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator


Current Employees Featured

thomas-martz_image

Thomas Martz
Thomas Martz Entrepreneur-In-Residence @ Droia Ventures
Entrepreneur-In-Residence
2021-10-01

luc-verelst_image

Luc Verelst
Luc Verelst Founder & Chairman @ Droia Ventures
Founder & Chairman

bart-van-hooland_image

Bart Van Hooland
Bart Van Hooland Managing Partner @ Droia Ventures
Managing Partner

Founder


bart-van-hooland_image

Bart Van Hooland

luc-verelst_image

Luc Verelst

Investments List

Date Company Article Money raised
2022-07-28 Vicinitas Therapeutics Droia Ventures investment in Series A - Vicinitas Therapeutics 65 M USD
2022-01-06 AmbAgon Therapeutics Droia Ventures investment in Series A - AmbAgon Therapeutics 85 M USD
2021-07-19 Frontier Medicines Droia Ventures investment in Series B - Frontier Medicines 88.5 M USD
2021-07-09 Muna Therapeutics Droia Ventures investment in Series A - Muna Therapeutics 73 M USD
2021-05-18 Hummingbird Bioscience Droia Ventures investment in Series C - Hummingbird Bioscience 125 M USD
2021-04-06 Volastra Therapeutics Droia Ventures investment in Seed Round - Volastra Therapeutics 32 M USD
2021-02-11 Cyteir Therapeutics Droia Ventures investment in Series C - Cyteir Therapeutics 80 M USD
2020-07-29 Vico Therapeutics Droia Ventures investment in Series A - Vico Therapeutics 31 M USD
2020-05-13 QurAlis Droia Ventures investment in Series A - QurAlis 42 M USD
2020-04-23 Accent Therapeutics Droia Ventures investment in Series B - Accent Therapeutics 63 M USD

More informations about "Droia Ventures"

Droia Ventures - Crunchbase Investor Profile

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in newly founded or early-stage platform companies that apply novel science and innovative …See details»

Droia Ventures - Org Chart, Teams, Culture & Jobs - The Org

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to …See details»

Droia Ventures - Investments, Portfolio & Company Exits

Droia Ventures 's most notable exits include Arcus Biosciences and Cyteir Therapeutics. Which industries has this organization had the most exits in? Show . Arcus Biosciences Arcus …See details»

Droia Ventures' Leadership Team Team - Team members and org …

The leadership team at Droia Ventures has a history of experience in various industries including biotechnology, law, and business administration. Many members of the team have also …See details»

Droia Ventures investment portfolio - PitchBook

Droia Ventures's latest investment was on 19-Dec-2024 in Alesta Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how …See details»

Droia N.V. (BE) - life-sciences-europe.com

Apr 30, 2020 "Press Release: Droia Ventures Raises a New Fund of EUR 220 Million to Target Genetic Diseases and Expands Leadership Team with George Golumbeski". Brussels. Record …See details»

DROIA Ventures - F6S

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. Droia invests in novel science and innovative approaches to bring promising drug candidates …See details»

Droia Oncology Ventures - life-sciences-europe.com

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia manages over EUR 450 million (USD 550 million) which it invests …See details»

Droia Ventures - Funding, Financials, Valuation & Investors

Droia Ventures has raised a single venture fund, Droia Ventures Fund III. This fund was announced on May 11, 2021 and raised a total of . obfuscated. obfuscated. Announced Date . …See details»

Droia Ventures III: Fund Performance - PitchBook

Droia Ventures III is a 2020 vintage venture capital fund managed by Droia Ventures. The fund is based in Zaventem, Belgium and invests in the United States, andEurope. It targets …See details»

Droia Ventures - EU-Startups

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in young drug development companies that use novel …See details»

DROIA Ventures | MAGNiTT

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. Droia invests in novel science and innovative approaches to bring promising drug candidates …See details»

Droia Genetic Disease Fund - life-sciences-europe.com

Apr 30, 2020 Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia manages over EUR 450 million (USD 550 million) which …See details»

Richard Pushkin, MD - Madrigal Pharmaceuticals - LinkedIn

The Series A was recently closed and co-led by Atlas Venture, TCG and Droia Ventures, with participation from Digitalis Ventures, EUCLIDEAN CAPITAL, LLC Capital, YK Bioventures.See details»

DMV VENTURES, LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for DMV VENTURES, LLC of Woodbridge, VA. Get the latest business insights from Dun & Bradstreet.See details»

Droia Ventures. (5/11/21). "Press Release: Droia Ventures Raises a …

Upcoming Events. Life Science Start-up Day 2025 Göttingen; AGBT 2025 Marco Island, Florida; BioAsia 2025 Hyderabad; AMR Conference 2025 Basel; Sachs Annual European Life …See details»

Why Startup Studios Are The Ultimate Builders Of Deep-Tech …

1 day ago Unlike digital ventures, which can iterate and pivot quickly, deep-tech startups face long R&D cycles, capital-intensive prototyping, regulatory complexity and fragmented value …See details»

Droia Ventures - Contacts, Employees, Board Members

Droia Ventures has 3 current employee profiles, including Entrepreneur-In-Residence Thomas Martz. Droia Ventures has 1 board member or advisor, Daniel Nomura. Contacts. Edit …See details»

BENEFIT VENTURES CORPORATION - WOODBRIDGE, NJ

BENEFIT VENTURES CORPORATION B. BENEFIT VENTURES CORPORATION CLAIM THIS BUSINESS. 1480 ROUTE 9 N STE 203 WOODBRIDGE, NJ 07095 Get Directions (732) 855 …See details»

What Made Menlo Ventures Bet on Anthropic? - Analytics India …

1 day ago AI startup Anthropic, founded in 2021 and led by former OpenAI employees Dario and Daniela Amodei, recently raised $3.5 billion in a funding round, valuing the company at $61.5 …See details»